Axonics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000160375624000077 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $345.2M
YoY Change 0.15%
Cash & Equivalents $239.5M
Short-Term Investments $105.8M
Other Short-Term Assets $4.184M
YoY Change -38.47%
Inventory $113.9M
Prepaid Expenses
Receivables $62.64M
Other Receivables $0.00
Total Short-Term Assets $525.9M
YoY Change 10.63%
LONG-TERM ASSETS
Property, Plant & Equipment $41.60M
YoY Change 534.5%
Goodwill $104.5M
YoY Change 9.72%
Intangibles $78.45M
YoY Change -2.27%
Long-Term Investments
YoY Change
Other Assets $22.48M
YoY Change 592.7%
Total Long-Term Assets $248.3M
YoY Change 33.93%
TOTAL ASSETS
Total Short-Term Assets $525.9M
Total Long-Term Assets $248.3M
Total Assets $774.2M
YoY Change 17.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.11M
YoY Change 37.11%
Accrued Expenses $5.701M
YoY Change -4.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.42M
YoY Change 80.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $29.90M
YoY Change 3222.22%
Total Long-Term Liabilities $29.90M
YoY Change 3222.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.42M
Total Long-Term Liabilities $29.90M
Total Liabilities $109.7M
YoY Change 118.81%
SHAREHOLDERS EQUITY
Retained Earnings -$392.6M
YoY Change 1.47%
Common Stock $5.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $664.5M
YoY Change
Total Liabilities & Shareholders Equity $774.2M
YoY Change 17.17%

Cashflow Statement

Concept 2024 Q4 2024 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001603756
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Axonics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AXNX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29900000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25840000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10703000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51110021 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51110021 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50770520 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50770520 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1063185000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1033778000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392586000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-380352000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6115000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15867000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
664489000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
637564000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
774171000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
719923000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116193000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93100000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
322167000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256644000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26542000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23996000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37339000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25172000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23761000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11778000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34659000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52972000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
47544000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
160607000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
134468000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2302000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6722000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6803000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2368000 usd
CY2024Q3 axnx In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
0 usd
CY2023Q3 axnx In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
0 usd
us-gaap Operating Expenses
OperatingExpenses
269813000 usd
us-gaap Operating Expenses
OperatingExpenses
218917000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6268000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-687000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21766000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
12149000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
774000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4712000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4188000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13296000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12923000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1556000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3501000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8470000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14200000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1535000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-427000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3764000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1538000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-21000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3928000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12234000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12662000 usd
CY2023Q3 axnx Replacement Of Damaged Or Defective Products Cost
ReplacementOfDamagedOrDefectiveProductsCost
0 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51109154 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104811000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
105773000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
64419000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45816000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15363000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
109682000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
82359000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
74120000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64850000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
89651000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
69104000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2221000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
95919000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-27123000 usd
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
4704000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
4271000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
13379000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
10438000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6185000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9752000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
636000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10417000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2257000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2482000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12026000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51088073 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49244981 shares
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2792000 usd
us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
0 usd
us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
0 usd
CY2024Q3 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
0 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
5200000 usd
us-gaap Advertising Expense
AdvertisingExpense
13600000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1676402 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2144827 shares
us-gaap Operating Lease Payments
OperatingLeasePayments
1600000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
144009000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147323000 usd
axnx In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
15447000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
69791000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
22082000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12714000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
20698000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
10760000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78454000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
81375000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22478000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24235000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
104545000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35998000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15060000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2611000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1777000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1198000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
442000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62644000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57243000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
113861000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
79940000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
99417000 usd
CY2024Q3 us-gaap Assets
Assets
774171000 usd
CY2023Q4 us-gaap Assets
Assets
719923000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
20109000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18452000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5701000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10527000 usd
us-gaap Gross Profit
GrossProfit
248047000 usd
us-gaap Gross Profit
GrossProfit
191794000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13491000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8167000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55192000 usd
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3474000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51010885 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48973252 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51088073 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50086491 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51010885 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48973252 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
637564000 usd
CY2024Q1 axnx Stock Issued During Period Value Stock Options Exercised Cash
StockIssuedDuringPeriodValueStockOptionsExercisedCash
248000 usd
CY2024Q1 axnx Apic Share Based Payment Arrangement Restricted Stock Award Increase For Cost Recognition
APICShareBasedPaymentArrangementRestrictedStockAwardIncreaseForCostRecognition
8106000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1445000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1152000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-19112000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
627099000 usd
CY2024Q2 axnx Stock Issued During Period Value Stock Options Exercised Cash
StockIssuedDuringPeriodValueStockOptionsExercisedCash
241000 usd
CY2024Q2 axnx Apic Share Based Payment Arrangement Restricted Stock Award Increase For Cost Recognition
APICShareBasedPaymentArrangementRestrictedStockAwardIncreaseForCostRecognition
7937000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
674000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
466000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
6899000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
643316000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
3419000 usd
CY2024Q3 axnx Replacement Of Damaged Or Defective Products Cost
ReplacementOfDamagedOrDefectiveProductsCost
0 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4744083
dei Entity Address Address Line1
EntityAddressAddressLine1
26 Technology Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
396-6322
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
239452000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
240149000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4184000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9279000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
525914000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
491422000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9953000 usd
axnx In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
0 usd
CY2024Q3 axnx Stock Issued During Period Value Stock Options Exercised Cash
StockIssuedDuringPeriodValueStockOptionsExercisedCash
2525000 usd
CY2024Q3 axnx Apic Share Based Payment Arrangement Restricted Stock Award Increase For Cost Recognition
APICShareBasedPaymentArrangementRestrictedStockAwardIncreaseForCostRecognition
7550000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
681000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
10438000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-21000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
664489000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
570139000 usd
CY2023Q1 axnx Stock Issued During Period Value Stock Options Exercised Cash
StockIssuedDuringPeriodValueStockOptionsExercisedCash
1930000 usd
CY2023Q1 axnx Apic Share Based Payment Arrangement Restricted Stock Award Increase For Cost Recognition
APICShareBasedPaymentArrangementRestrictedStockAwardIncreaseForCostRecognition
7295000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3071000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-9248000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
576606000 usd
CY2023Q2 axnx Stock Issued During Period Value Stock Options Exercised Cash
StockIssuedDuringPeriodValueStockOptionsExercisedCash
864000 usd
CY2023Q2 axnx Apic Share Based Payment Arrangement Restricted Stock Award Increase For Cost Recognition
APICShareBasedPaymentArrangementRestrictedStockAwardIncreaseForCostRecognition
7676000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
3528000 usd
CY2023Q2 axnx Stock Issued During Period Value In Process Research And Development
StockIssuedDuringPeriodValueInProcessResearchAndDevelopment
15447000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3750000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7342000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
600529000 usd
CY2023Q3 axnx Stock Issued During Period Value Stock Options Exercised Cash
StockIssuedDuringPeriodValueStockOptionsExercisedCash
878000 usd
CY2023Q3 axnx Apic Share Based Payment Arrangement Restricted Stock Award Increase For Cost Recognition
APICShareBasedPaymentArrangementRestrictedStockAwardIncreaseForCostRecognition
8678000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6185000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3928000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
610620000 usd
us-gaap Profit Loss
ProfitLoss
-12234000 usd
us-gaap Profit Loss
ProfitLoss
-12662000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9298000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9295000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26393000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
33388000 usd
axnx In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
0 usd
axnx In Process Research And Development Expense
InProcessResearchAndDevelopmentExpense
15447000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
756000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2400000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
4042000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2896000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
4016000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
208000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6016000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4164000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
37620000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19326000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-666000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1814000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
778000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2326000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1564000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5577000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4829000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-623000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
20931000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2502000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2475000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-337000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-27370000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8664000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7646000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7614000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2243000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
240244000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
288914000 usd
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
379046000 usd
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
212175000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
131188000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78982000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7630000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3014000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3672000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3014000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3958000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1143000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-937000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-91523000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117525000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238846000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261534000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
55000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
848000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
94000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7000 usd
axnx Property And Equipment Acquired From Tenant Improvement Allowance
PropertyAndEquipmentAcquiredFromTenantImprovementAllowance
4900000 usd
axnx Property And Equipment Acquired From Tenant Improvement Allowance
PropertyAndEquipmentAcquiredFromTenantImprovementAllowance
0 usd
axnx Stock Issued During Period Value In Process Research And Development
StockIssuedDuringPeriodValueInProcessResearchAndDevelopment
0 usd
axnx Stock Issued During Period Value In Process Research And Development
StockIssuedDuringPeriodValueInProcessResearchAndDevelopment
15447000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12700000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392600000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-380400000 usd
CY2024Q3 axnx Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
367300000 usd
CY2023Q4 axnx Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
357700000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and judgments that affect the reported amounts of assets, liabilities, and expenses, and related disclosures of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. The results of this evaluation then form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates, and such differences may be material to the consolidated financial statements. Such estimates and assumptions include the useful lives of property and equipment and intangible assets, the valuation of deferred income tax assets and liabilities, the valuation of contingent consideration liability, the valuation of stock-based compensation, the product returns reserve, the inventory obsolescence reserve and accounts receivable allowance for credit losses.</span></div>
CY2024Q3 axnx Accounts Receivable Allowancefor Product Returns
AccountsReceivableAllowanceforProductReturns
300000 usd
CY2023Q4 axnx Accounts Receivable Allowancefor Product Returns
AccountsReceivableAllowanceforProductReturns
300000 usd
axnx Replacement Of Damaged Or Defective Products Cost
ReplacementOfDamagedOrDefectiveProductsCost
100000 usd
axnx Replacement Of Damaged Or Defective Products Cost
ReplacementOfDamagedOrDefectiveProductsCost
100000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
200000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
100000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116193000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93100000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
322167000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256644000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
442000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
321000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
165000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
12000 usd
axnx Accounts Receivable Allowance For Credit Loss Expense Recovery
AccountsReceivableAllowanceForCreditLossExpenseRecovery
921000 usd
axnx Accounts Receivable Allowance For Credit Loss Expense Recovery
AccountsReceivableAllowanceForCreditLossExpenseRecovery
71000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1198000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
380000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
239452000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104811000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
22082000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12714000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261534000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117525000 usd
CY2023Q3 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
0 usd
CY2024Q3 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
109600000 usd
CY2024Q3 us-gaap Us Government Agencies Securities At Carrying Value
USGovernmentAgenciesSecuritiesAtCarryingValue
39900000 usd
CY2024Q3 axnx Corporate Notes At Carrying Value
CorporateNotesAtCarryingValue
3800000 usd
CY2023Q4 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
49700000 usd
CY2024Q3 axnx Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
153292000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
153292000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
105767000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
105773000 usd
CY2024Q3 axnx Cash And Cash Equivalents And Debt Securities Available For Sale Amortized Cost
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCost
259059000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q3 axnx Cash And Cash Equivalents And Debt Securities Available For Sale Fair Value
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleFairValue
259065000 usd
CY2023Q4 axnx Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
49714000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
49714000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
240103000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
67000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
21000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
240149000 usd
CY2023Q4 axnx Cash And Cash Equivalents And Debt Securities Available For Sale Amortized Cost
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCost
289817000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
67000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
21000 usd
CY2023Q4 axnx Cash And Cash Equivalents And Debt Securities Available For Sale Fair Value
CashAndCashEquivalentsAndDebtSecuritiesAvailableForSaleFairValue
289863000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
81100000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10700000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22100000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6300000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
48900000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10500000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
20500000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2300000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
5900000 usd
us-gaap Advertising Expense
AdvertisingExpense
16900000 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1481838 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
33592000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
21625000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
12894000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
10865000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
20698000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
10760000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20900000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22500000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
400000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
600000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
500000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1600000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
100000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1233000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
528000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3768000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1616000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
16000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
25000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
48000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
70000 usd
CY2024Q3 axnx Variable Lease Cost Refund
VariableLeaseCostRefund
-827000 usd
CY2023Q3 axnx Variable Lease Cost Refund
VariableLeaseCostRefund
167000 usd
axnx Variable Lease Cost Refund
VariableLeaseCostRefund
712000 usd
axnx Variable Lease Cost Refund
VariableLeaseCostRefund
452000 usd
CY2024Q3 axnx Amortization Of Net Lease Liabilities
AmortizationOfNetLeaseLiabilities
-870000 usd
CY2023Q3 axnx Amortization Of Net Lease Liabilities
AmortizationOfNetLeaseLiabilities
549000 usd
axnx Amortization Of Net Lease Liabilities
AmortizationOfNetLeaseLiabilities
880000 usd
axnx Amortization Of Net Lease Liabilities
AmortizationOfNetLeaseLiabilities
1272000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
1292000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
171000 usd
us-gaap Lease Cost
LeaseCost
3648000 usd
us-gaap Lease Cost
LeaseCost
866000 usd
axnx Period After First Sale Royalty Is Due
PeriodAfterFirstSaleRoyaltyIsDue
P12Y
axnx Percentageof Net Revenue Due As Royalty
PercentageofNetRevenueDueAsRoyalty
0.04
CY2024Q3 us-gaap Royalty Expense
RoyaltyExpense
700000 usd
us-gaap Royalty Expense
RoyaltyExpense
2000000.0 usd
CY2023Q3 us-gaap Royalty Expense
RoyaltyExpense
600000 usd
us-gaap Royalty Expense
RoyaltyExpense
1700000 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
700000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
800000 usd
CY2024Q3 axnx Loss Contingency Patents Number Of Unpatentable Claims
LossContingencyPatentsNumberOfUnpatentableClaims
10 claim
CY2024Q3 axnx Loss Contingency Patents Number Of Claims
LossContingencyPatentsNumberOfClaims
15 claim
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8231000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11470000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26393000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33388000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
814780 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.47
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35652000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
132880 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6040000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1125 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
50.01
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
680775 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.60
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35401000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1535000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-427000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3764000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1538000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.9862
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.1220
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.4443
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1083
CY2024Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2400000 usd
CY2023Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
700000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1900000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
99417000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
5128000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
104545000 usd
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
116500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33215000 usd
CY2024Q3 axnx Impairment Of Intangible Assets Cumulative Finite Lived
ImpairmentOfIntangibleAssetsCumulativeFiniteLived
287000 usd
CY2024Q3 axnx Intangible Assets Foreign Exchange Adjustment
IntangibleAssetsForeignExchangeAdjustment
-4544000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78454000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
116500000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26493000 usd
CY2023Q4 axnx Impairment Of Intangible Assets Cumulative Finite Lived
ImpairmentOfIntangibleAssetsCumulativeFiniteLived
287000 usd
CY2023Q4 axnx Intangible Assets Foreign Exchange Adjustment
IntangibleAssetsForeignExchangeAdjustment
-8345000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
81375000 usd

Files In Submission

Name View Source Status
axnx-20240930_cal.xml Edgar Link unprocessable
0001603756-24-000077-index-headers.html Edgar Link pending
0001603756-24-000077-index.html Edgar Link pending
0001603756-24-000077.txt Edgar Link pending
0001603756-24-000077-xbrl.zip Edgar Link pending
a09302024-exhibit311.htm Edgar Link pending
a09302024-exhibit312.htm Edgar Link pending
a09302024-exhibit321.htm Edgar Link pending
a09302024-exhibit322.htm Edgar Link pending
axnx-20240930.htm Edgar Link pending
axnx-20240930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
axnx-20240930_lab.xml Edgar Link unprocessable
axnx-20240930_pre.xml Edgar Link unprocessable
axnx-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
axnx-20240930_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending